An evaluation of intermittent therapies used to treat onychomycosis and other dermatomycoses with the oral antifungal agents

Efficacy of Itraconazole in the Prophylactic Treatment of Pityriasis (Tinea) Versicolor

“…Prophylactic regimens using ketoconazole include 200 mg given on 3 consecutive days every month 20 or a single dose of 400 mg taken once a month. 21,22 Topical therapies have been used as a prophylactic, but patient compliance is lower, and no controlled studies have been reported in the literature, to our knowledge.…”

In vitro susceptibility testing of dermatophytes isolated in Goiania, Brazil, against five antifungal agents by broth microdilution method

“…In Goiania city, Brazil, these same etiological agents have been recovered in studies of COSTA et al 6,7 . Antifungal agents such as triazoles (itraconazole, fluconazole), imidazole (ketoconazole), allylamine (terbinafine) and griseofulvin have been reported to have substantial activity in dermatophytosis 16,17 . However, infections due to dermatophytes are often associated with relapses after cessation of therapy 20 .…”

In vitro susceptibility testing of dermatophytes isolated from pediatric cases in Nigeria against five antifungals

“…Several therapeutic regimens are reported to have activity in these fungi and are therefore being used in treating it 9,17 . Although in the last few years, there has been a steady introduction of new drugs by either modification of pre-existing or entirely new chemical classes of antimycotics, there has also been an increased interest in clinically relevant susceptibility testing 16 .…”